nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—CYP1A2—Anagrelide—hematologic cancer	0.03	0.0596	CbGbCtD
Mirtazapine—CYP2C9—Bexarotene—hematologic cancer	0.0187	0.0373	CbGbCtD
Mirtazapine—CYP2C8—Bortezomib—hematologic cancer	0.0165	0.0327	CbGbCtD
Mirtazapine—CYP2D6—Lomustine—hematologic cancer	0.0159	0.0317	CbGbCtD
Mirtazapine—CYP1A2—Carmustine—hematologic cancer	0.0158	0.0313	CbGbCtD
Mirtazapine—CYP2C9—Idarubicin—hematologic cancer	0.0155	0.0309	CbGbCtD
Mirtazapine—CYP2D6—Idarubicin—hematologic cancer	0.0142	0.0282	CbGbCtD
Mirtazapine—CYP1A2—Methoxsalen—hematologic cancer	0.0134	0.0266	CbGbCtD
Mirtazapine—CYP1A2—Bortezomib—hematologic cancer	0.0127	0.0253	CbGbCtD
Mirtazapine—CYP2C8—Ifosfamide—hematologic cancer	0.0126	0.0251	CbGbCtD
Mirtazapine—CYP1A2—Daunorubicin—hematologic cancer	0.0122	0.0242	CbGbCtD
Mirtazapine—CYP2D6—Hydroxyurea—hematologic cancer	0.0121	0.024	CbGbCtD
Mirtazapine—CYP1A2—Alitretinoin—hematologic cancer	0.0119	0.0237	CbGbCtD
Mirtazapine—CYP2C9—Bortezomib—hematologic cancer	0.0115	0.0228	CbGbCtD
Mirtazapine—CYP1A2—Thalidomide—hematologic cancer	0.0111	0.0221	CbGbCtD
Mirtazapine—CYP2C8—Nilotinib—hematologic cancer	0.011	0.0218	CbGbCtD
Mirtazapine—CYP3A4—Bexarotene—hematologic cancer	0.0109	0.0217	CbGbCtD
Mirtazapine—CYP2D6—Bortezomib—hematologic cancer	0.0105	0.0209	CbGbCtD
Mirtazapine—CYP3A4—Busulfan—hematologic cancer	0.0101	0.0201	CbGbCtD
Mirtazapine—CYP3A4—Lomustine—hematologic cancer	0.0101	0.0201	CbGbCtD
Mirtazapine—CYP2C9—Thalidomide—hematologic cancer	0.01	0.0199	CbGbCtD
Mirtazapine—CYP1A2—Dacarbazine—hematologic cancer	0.00955	0.019	CbGbCtD
Mirtazapine—CYP2C9—Teniposide—hematologic cancer	0.00954	0.019	CbGbCtD
Mirtazapine—CYP1A2—Imatinib—hematologic cancer	0.00934	0.0186	CbGbCtD
Mirtazapine—CYP3A4—Thiotepa—hematologic cancer	0.00903	0.0179	CbGbCtD
Mirtazapine—CYP2C9—Ifosfamide—hematologic cancer	0.00881	0.0175	CbGbCtD
Mirtazapine—CYP2C9—Imatinib—hematologic cancer	0.00841	0.0167	CbGbCtD
Mirtazapine—CYP2D6—Imatinib—hematologic cancer	0.00769	0.0153	CbGbCtD
Mirtazapine—CYP2C9—Nilotinib—hematologic cancer	0.00765	0.0152	CbGbCtD
Mirtazapine—CYP1A2—Dasatinib—hematologic cancer	0.0075	0.0149	CbGbCtD
Mirtazapine—CYP3A4—Methoxsalen—hematologic cancer	0.00702	0.014	CbGbCtD
Mirtazapine—CYP2D6—Nilotinib—hematologic cancer	0.00699	0.0139	CbGbCtD
Mirtazapine—CYP2D6—Vinorelbine—hematologic cancer	0.00693	0.0138	CbGbCtD
Mirtazapine—CYP3A4—Bortezomib—hematologic cancer	0.00668	0.0133	CbGbCtD
Mirtazapine—CYP3A4—Daunorubicin—hematologic cancer	0.00639	0.0127	CbGbCtD
Mirtazapine—CYP2C8—Etoposide—hematologic cancer	0.00603	0.012	CbGbCtD
Mirtazapine—CYP3A4—Cytarabine—hematologic cancer	0.00563	0.0112	CbGbCtD
Mirtazapine—CYP3A4—Teniposide—hematologic cancer	0.00555	0.011	CbGbCtD
Mirtazapine—CYP3A4—Ifosfamide—hematologic cancer	0.00512	0.0102	CbGbCtD
Mirtazapine—CYP2C8—Dexamethasone—hematologic cancer	0.00496	0.00986	CbGbCtD
Mirtazapine—CYP3A4—Imatinib—hematologic cancer	0.00489	0.00973	CbGbCtD
Mirtazapine—CYP1A2—Etoposide—hematologic cancer	0.00467	0.00929	CbGbCtD
Mirtazapine—CYP3A4—Ruxolitinib—hematologic cancer	0.00461	0.00916	CbGbCtD
Mirtazapine—CYP3A4—Nilotinib—hematologic cancer	0.00445	0.00884	CbGbCtD
Mirtazapine—CYP3A4—Vinorelbine—hematologic cancer	0.00441	0.00876	CbGbCtD
Mirtazapine—CYP2C9—Cisplatin—hematologic cancer	0.00428	0.00852	CbGbCtD
Mirtazapine—CYP2D6—Vinblastine—hematologic cancer	0.00427	0.00849	CbGbCtD
Mirtazapine—CYP3A4—Triamcinolone—hematologic cancer	0.00403	0.00802	CbGbCtD
Mirtazapine—CYP3A4—Dasatinib—hematologic cancer	0.00393	0.00781	CbGbCtD
Mirtazapine—CYP3A4—Mitoxantrone—hematologic cancer	0.00388	0.00772	CbGbCtD
Mirtazapine—CYP2C9—Dexamethasone—hematologic cancer	0.00346	0.00688	CbGbCtD
Mirtazapine—CYP3A4—Betamethasone—hematologic cancer	0.00346	0.00688	CbGbCtD
Mirtazapine—CYP3A4—Prednisolone—hematologic cancer	0.00341	0.00679	CbGbCtD
Mirtazapine—CYP3A4—Prednisone—hematologic cancer	0.00322	0.00641	CbGbCtD
Mirtazapine—CYP2D6—Dexamethasone—hematologic cancer	0.00316	0.00629	CbGbCtD
Mirtazapine—CYP3A4—Irinotecan—hematologic cancer	0.00306	0.00608	CbGbCtD
Mirtazapine—HRH3—hematopoietic system—hematologic cancer	0.00274	0.0727	CbGeAlD
Mirtazapine—CYP3A4—Vinblastine—hematologic cancer	0.00272	0.0054	CbGbCtD
Mirtazapine—CYP3A4—Vincristine—hematologic cancer	0.00267	0.00531	CbGbCtD
Mirtazapine—CYP2D6—Doxorubicin—hematologic cancer	0.00262	0.00522	CbGbCtD
Mirtazapine—CYP3A4—Etoposide—hematologic cancer	0.00245	0.00487	CbGbCtD
Mirtazapine—CYP3A4—Dexamethasone—hematologic cancer	0.00201	0.004	CbGbCtD
Mirtazapine—HRH3—blood—hematologic cancer	0.00181	0.0481	CbGeAlD
Mirtazapine—CYP3A4—Doxorubicin—hematologic cancer	0.00167	0.00332	CbGbCtD
Mirtazapine—DRD4—testis—hematologic cancer	0.00148	0.0393	CbGeAlD
Mirtazapine—HTR3A—hematopoietic system—hematologic cancer	0.00131	0.0348	CbGeAlD
Mirtazapine—SLC6A3—hematopoietic system—hematologic cancer	0.00109	0.029	CbGeAlD
Mirtazapine—SLC6A4—hematopoietic system—hematologic cancer	0.001	0.0266	CbGeAlD
Mirtazapine—HTR1A—hematopoietic system—hematologic cancer	0.000889	0.0236	CbGeAlD
Mirtazapine—HTR3A—blood—hematologic cancer	0.00087	0.0231	CbGeAlD
Mirtazapine—HTR7—hematopoietic system—hematologic cancer	0.000849	0.0225	CbGeAlD
Mirtazapine—ADRA1A—hematopoietic system—hematologic cancer	0.000819	0.0217	CbGeAlD
Mirtazapine—HTR3A—lung—hematologic cancer	0.000762	0.0202	CbGeAlD
Mirtazapine—CYP2C8—hematopoietic system—hematologic cancer	0.000724	0.0192	CbGeAlD
Mirtazapine—CYP1A2—hematopoietic system—hematologic cancer	0.000677	0.018	CbGeAlD
Mirtazapine—SLC6A2—gonad—hematologic cancer	0.00067	0.0178	CbGeAlD
Mirtazapine—SLC6A4—blood—hematologic cancer	0.000663	0.0176	CbGeAlD
Mirtazapine—HTR2B—blood—hematologic cancer	0.000657	0.0174	CbGeAlD
Mirtazapine—HTR7—gonad—hematologic cancer	0.000646	0.0171	CbGeAlD
Mirtazapine—CYP2C9—hematopoietic system—hematologic cancer	0.000643	0.0171	CbGeAlD
Mirtazapine—SLC6A3—lung—hematologic cancer	0.000634	0.0168	CbGeAlD
Mirtazapine—HRH1—hematopoietic system—hematologic cancer	0.000634	0.0168	CbGeAlD
Mirtazapine—ADRA2A—hematopoietic system—hematologic cancer	0.000623	0.0165	CbGeAlD
Mirtazapine—ADRB1—lung—hematologic cancer	0.000602	0.016	CbGeAlD
Mirtazapine—SLC6A3—testis—hematologic cancer	0.000599	0.0159	CbGeAlD
Mirtazapine—SLC6A4—lung—hematologic cancer	0.000581	0.0154	CbGeAlD
Mirtazapine—HTR2B—lung—hematologic cancer	0.000576	0.0153	CbGeAlD
Mirtazapine—HTR7—blood—hematologic cancer	0.000563	0.0149	CbGeAlD
Mirtazapine—ADRA1A—blood—hematologic cancer	0.000543	0.0144	CbGeAlD
Mirtazapine—HTR2A—hematopoietic system—hematologic cancer	0.00053	0.0141	CbGeAlD
Mirtazapine—ADRA2C—blood—hematologic cancer	0.000517	0.0137	CbGeAlD
Mirtazapine—SLC6A2—lung—hematologic cancer	0.000512	0.0136	CbGeAlD
Mirtazapine—HTR7—lung—hematologic cancer	0.000493	0.0131	CbGeAlD
Mirtazapine—CYP3A4—hematopoietic system—hematologic cancer	0.00049	0.013	CbGeAlD
Mirtazapine—SLC6A2—testis—hematologic cancer	0.000483	0.0128	CbGeAlD
Mirtazapine—CYP2D6—hematopoietic system—hematologic cancer	0.000482	0.0128	CbGeAlD
Mirtazapine—CYP2C8—blood—hematologic cancer	0.00048	0.0127	CbGeAlD
Mirtazapine—ADRA2A—gonad—hematologic cancer	0.000474	0.0126	CbGeAlD
Mirtazapine—DRD2—lung—hematologic cancer	0.000466	0.0124	CbGeAlD
Mirtazapine—HTR7—testis—hematologic cancer	0.000465	0.0123	CbGeAlD
Mirtazapine—ADRA2C—lung—hematologic cancer	0.000453	0.012	CbGeAlD
Mirtazapine—CYP1A2—blood—hematologic cancer	0.000449	0.0119	CbGeAlD
Mirtazapine—DRD2—testis—hematologic cancer	0.00044	0.0117	CbGeAlD
Mirtazapine—ADRA2C—testis—hematologic cancer	0.000428	0.0113	CbGeAlD
Mirtazapine—CYP2C9—blood—hematologic cancer	0.000426	0.0113	CbGeAlD
Mirtazapine—ADRA2A—blood—hematologic cancer	0.000413	0.0109	CbGeAlD
Mirtazapine—HTR2A—gonad—hematologic cancer	0.000403	0.0107	CbGeAlD
Mirtazapine—CYP2C8—testis—hematologic cancer	0.000397	0.0105	CbGeAlD
Mirtazapine—HTR2B—lymph node—hematologic cancer	0.000394	0.0105	CbGeAlD
Mirtazapine—CYP1A2—lung—hematologic cancer	0.000393	0.0104	CbGeAlD
Mirtazapine—HRH1—lung—hematologic cancer	0.000368	0.00977	CbGeAlD
Mirtazapine—ADRA2A—lung—hematologic cancer	0.000362	0.0096	CbGeAlD
Mirtazapine—HTR2A—blood—hematologic cancer	0.000351	0.00931	CbGeAlD
Mirtazapine—SLC6A2—lymph node—hematologic cancer	0.00035	0.00929	CbGeAlD
Mirtazapine—HRH1—testis—hematologic cancer	0.000347	0.00922	CbGeAlD
Mirtazapine—ADRA2A—testis—hematologic cancer	0.000341	0.00906	CbGeAlD
Mirtazapine—CYP3A4—blood—hematologic cancer	0.000325	0.00862	CbGeAlD
Mirtazapine—CYP2D6—blood—hematologic cancer	0.00032	0.00848	CbGeAlD
Mirtazapine—ADRA2C—lymph node—hematologic cancer	0.00031	0.00823	CbGeAlD
Mirtazapine—HTR2A—lung—hematologic cancer	0.000308	0.00816	CbGeAlD
Mirtazapine—HTR2A—testis—hematologic cancer	0.00029	0.0077	CbGeAlD
Mirtazapine—CYP2D6—testis—hematologic cancer	0.000264	0.00702	CbGeAlD
Mirtazapine—HRH1—lymph node—hematologic cancer	0.000252	0.00668	CbGeAlD
Mirtazapine—ADRA2A—lymph node—hematologic cancer	0.000247	0.00656	CbGeAlD
Mirtazapine—Malnutrition—Epirubicin—hematologic cancer	1.86e-05	5.55e-05	CcSEcCtD
Mirtazapine—Diarrhoea—Etoposide—hematologic cancer	1.85e-05	5.52e-05	CcSEcCtD
Mirtazapine—Anorexia—Prednisone—hematologic cancer	1.85e-05	5.52e-05	CcSEcCtD
Mirtazapine—Eye disorder—Doxorubicin—hematologic cancer	1.84e-05	5.51e-05	CcSEcCtD
Mirtazapine—Ill-defined disorder—Methotrexate—hematologic cancer	1.84e-05	5.5e-05	CcSEcCtD
Mirtazapine—Tinnitus—Doxorubicin—hematologic cancer	1.84e-05	5.5e-05	CcSEcCtD
Mirtazapine—Anaemia—Methotrexate—hematologic cancer	1.83e-05	5.48e-05	CcSEcCtD
Mirtazapine—Feeling abnormal—Betamethasone—hematologic cancer	1.83e-05	5.48e-05	CcSEcCtD
Mirtazapine—Feeling abnormal—Dexamethasone—hematologic cancer	1.83e-05	5.48e-05	CcSEcCtD
Mirtazapine—Cardiac disorder—Doxorubicin—hematologic cancer	1.83e-05	5.47e-05	CcSEcCtD
Mirtazapine—Flatulence—Epirubicin—hematologic cancer	1.83e-05	5.46e-05	CcSEcCtD
Mirtazapine—Tension—Epirubicin—hematologic cancer	1.82e-05	5.44e-05	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Betamethasone—hematologic cancer	1.82e-05	5.43e-05	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.82e-05	5.43e-05	CcSEcCtD
Mirtazapine—Dysgeusia—Epirubicin—hematologic cancer	1.82e-05	5.43e-05	CcSEcCtD
Mirtazapine—Hypersensitivity—Triamcinolone—hematologic cancer	1.81e-05	5.4e-05	CcSEcCtD
Mirtazapine—Nervousness—Epirubicin—hematologic cancer	1.8e-05	5.39e-05	CcSEcCtD
Mirtazapine—Back pain—Epirubicin—hematologic cancer	1.8e-05	5.36e-05	CcSEcCtD
Mirtazapine—Angiopathy—Doxorubicin—hematologic cancer	1.79e-05	5.35e-05	CcSEcCtD
Mirtazapine—Malaise—Methotrexate—hematologic cancer	1.79e-05	5.34e-05	CcSEcCtD
Mirtazapine—Dizziness—Etoposide—hematologic cancer	1.79e-05	5.34e-05	CcSEcCtD
Mirtazapine—Vertigo—Methotrexate—hematologic cancer	1.78e-05	5.32e-05	CcSEcCtD
Mirtazapine—Leukopenia—Methotrexate—hematologic cancer	1.78e-05	5.3e-05	CcSEcCtD
Mirtazapine—Chills—Doxorubicin—hematologic cancer	1.77e-05	5.29e-05	CcSEcCtD
Mirtazapine—Urticaria—Betamethasone—hematologic cancer	1.77e-05	5.28e-05	CcSEcCtD
Mirtazapine—Urticaria—Dexamethasone—hematologic cancer	1.77e-05	5.28e-05	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.76e-05	5.27e-05	CcSEcCtD
Mirtazapine—Dizziness—Prednisolone—hematologic cancer	1.76e-05	5.27e-05	CcSEcCtD
Mirtazapine—Arrhythmia—Doxorubicin—hematologic cancer	1.76e-05	5.27e-05	CcSEcCtD
Mirtazapine—Asthenia—Triamcinolone—hematologic cancer	1.76e-05	5.25e-05	CcSEcCtD
Mirtazapine—Body temperature increased—Dexamethasone—hematologic cancer	1.76e-05	5.25e-05	CcSEcCtD
Mirtazapine—Abdominal pain—Dexamethasone—hematologic cancer	1.76e-05	5.25e-05	CcSEcCtD
Mirtazapine—Abdominal pain—Betamethasone—hematologic cancer	1.76e-05	5.25e-05	CcSEcCtD
Mirtazapine—Body temperature increased—Betamethasone—hematologic cancer	1.76e-05	5.25e-05	CcSEcCtD
Mirtazapine—Nausea—Cisplatin—hematologic cancer	1.75e-05	5.24e-05	CcSEcCtD
Mirtazapine—Insomnia—Prednisone—hematologic cancer	1.75e-05	5.23e-05	CcSEcCtD
Mirtazapine—Alopecia—Doxorubicin—hematologic cancer	1.74e-05	5.21e-05	CcSEcCtD
Mirtazapine—Paraesthesia—Prednisone—hematologic cancer	1.74e-05	5.2e-05	CcSEcCtD
Mirtazapine—Pruritus—Triamcinolone—hematologic cancer	1.73e-05	5.18e-05	CcSEcCtD
Mirtazapine—Cough—Methotrexate—hematologic cancer	1.73e-05	5.17e-05	CcSEcCtD
Mirtazapine—Mental disorder—Doxorubicin—hematologic cancer	1.73e-05	5.16e-05	CcSEcCtD
Mirtazapine—Ill-defined disorder—Epirubicin—hematologic cancer	1.72e-05	5.15e-05	CcSEcCtD
Mirtazapine—Convulsion—Methotrexate—hematologic cancer	1.72e-05	5.13e-05	CcSEcCtD
Mirtazapine—Vomiting—Etoposide—hematologic cancer	1.72e-05	5.13e-05	CcSEcCtD
Mirtazapine—Malnutrition—Doxorubicin—hematologic cancer	1.72e-05	5.13e-05	CcSEcCtD
Mirtazapine—Anaemia—Epirubicin—hematologic cancer	1.72e-05	5.13e-05	CcSEcCtD
Mirtazapine—Agitation—Epirubicin—hematologic cancer	1.71e-05	5.1e-05	CcSEcCtD
Mirtazapine—Dyspepsia—Prednisone—hematologic cancer	1.7e-05	5.09e-05	CcSEcCtD
Mirtazapine—Rash—Etoposide—hematologic cancer	1.7e-05	5.09e-05	CcSEcCtD
Mirtazapine—Dermatitis—Etoposide—hematologic cancer	1.7e-05	5.09e-05	CcSEcCtD
Mirtazapine—Headache—Etoposide—hematologic cancer	1.69e-05	5.06e-05	CcSEcCtD
Mirtazapine—Flatulence—Doxorubicin—hematologic cancer	1.69e-05	5.06e-05	CcSEcCtD
Mirtazapine—Chest pain—Methotrexate—hematologic cancer	1.69e-05	5.05e-05	CcSEcCtD
Mirtazapine—Arthralgia—Methotrexate—hematologic cancer	1.69e-05	5.05e-05	CcSEcCtD
Mirtazapine—Myalgia—Methotrexate—hematologic cancer	1.69e-05	5.05e-05	CcSEcCtD
Mirtazapine—Tension—Doxorubicin—hematologic cancer	1.69e-05	5.04e-05	CcSEcCtD
Mirtazapine—Decreased appetite—Prednisone—hematologic cancer	1.68e-05	5.03e-05	CcSEcCtD
Mirtazapine—Dysgeusia—Doxorubicin—hematologic cancer	1.68e-05	5.03e-05	CcSEcCtD
Mirtazapine—Rash—Prednisolone—hematologic cancer	1.68e-05	5.02e-05	CcSEcCtD
Mirtazapine—Dermatitis—Prednisolone—hematologic cancer	1.68e-05	5.02e-05	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.68e-05	5.01e-05	CcSEcCtD
Mirtazapine—Malaise—Epirubicin—hematologic cancer	1.67e-05	5e-05	CcSEcCtD
Mirtazapine—Fatigue—Prednisone—hematologic cancer	1.67e-05	4.99e-05	CcSEcCtD
Mirtazapine—Headache—Prednisolone—hematologic cancer	1.67e-05	4.99e-05	CcSEcCtD
Mirtazapine—Discomfort—Methotrexate—hematologic cancer	1.67e-05	4.98e-05	CcSEcCtD
Mirtazapine—Nervousness—Doxorubicin—hematologic cancer	1.67e-05	4.98e-05	CcSEcCtD
Mirtazapine—Vertigo—Epirubicin—hematologic cancer	1.67e-05	4.98e-05	CcSEcCtD
Mirtazapine—Syncope—Epirubicin—hematologic cancer	1.66e-05	4.97e-05	CcSEcCtD
Mirtazapine—Leukopenia—Epirubicin—hematologic cancer	1.66e-05	4.96e-05	CcSEcCtD
Mirtazapine—Back pain—Doxorubicin—hematologic cancer	1.66e-05	4.96e-05	CcSEcCtD
Mirtazapine—Constipation—Prednisone—hematologic cancer	1.66e-05	4.95e-05	CcSEcCtD
Mirtazapine—Palpitations—Epirubicin—hematologic cancer	1.64e-05	4.9e-05	CcSEcCtD
Mirtazapine—Confusional state—Methotrexate—hematologic cancer	1.63e-05	4.88e-05	CcSEcCtD
Mirtazapine—Loss of consciousness—Epirubicin—hematologic cancer	1.63e-05	4.87e-05	CcSEcCtD
Mirtazapine—Dizziness—Triamcinolone—hematologic cancer	1.62e-05	4.84e-05	CcSEcCtD
Mirtazapine—Cough—Epirubicin—hematologic cancer	1.62e-05	4.84e-05	CcSEcCtD
Mirtazapine—Convulsion—Epirubicin—hematologic cancer	1.61e-05	4.81e-05	CcSEcCtD
Mirtazapine—Infection—Methotrexate—hematologic cancer	1.61e-05	4.81e-05	CcSEcCtD
Mirtazapine—Nausea—Etoposide—hematologic cancer	1.61e-05	4.8e-05	CcSEcCtD
Mirtazapine—Hypertension—Epirubicin—hematologic cancer	1.6e-05	4.79e-05	CcSEcCtD
Mirtazapine—Feeling abnormal—Prednisone—hematologic cancer	1.6e-05	4.77e-05	CcSEcCtD
Mirtazapine—Asthenia—Dexamethasone—hematologic cancer	1.6e-05	4.77e-05	CcSEcCtD
Mirtazapine—Asthenia—Betamethasone—hematologic cancer	1.6e-05	4.77e-05	CcSEcCtD
Mirtazapine—Ill-defined disorder—Doxorubicin—hematologic cancer	1.59e-05	4.76e-05	CcSEcCtD
Mirtazapine—Nervous system disorder—Methotrexate—hematologic cancer	1.59e-05	4.74e-05	CcSEcCtD
Mirtazapine—Anaemia—Doxorubicin—hematologic cancer	1.59e-05	4.74e-05	CcSEcCtD
Mirtazapine—Thrombocytopenia—Methotrexate—hematologic cancer	1.58e-05	4.74e-05	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Prednisone—hematologic cancer	1.58e-05	4.73e-05	CcSEcCtD
Mirtazapine—Nausea—Prednisolone—hematologic cancer	1.58e-05	4.73e-05	CcSEcCtD
Mirtazapine—Arthralgia—Epirubicin—hematologic cancer	1.58e-05	4.72e-05	CcSEcCtD
Mirtazapine—Chest pain—Epirubicin—hematologic cancer	1.58e-05	4.72e-05	CcSEcCtD
Mirtazapine—Myalgia—Epirubicin—hematologic cancer	1.58e-05	4.72e-05	CcSEcCtD
Mirtazapine—Agitation—Doxorubicin—hematologic cancer	1.58e-05	4.72e-05	CcSEcCtD
Mirtazapine—Anxiety—Epirubicin—hematologic cancer	1.57e-05	4.71e-05	CcSEcCtD
Mirtazapine—Pruritus—Dexamethasone—hematologic cancer	1.57e-05	4.7e-05	CcSEcCtD
Mirtazapine—Pruritus—Betamethasone—hematologic cancer	1.57e-05	4.7e-05	CcSEcCtD
Mirtazapine—Skin disorder—Methotrexate—hematologic cancer	1.57e-05	4.7e-05	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.57e-05	4.69e-05	CcSEcCtD
Mirtazapine—Hyperhidrosis—Methotrexate—hematologic cancer	1.56e-05	4.68e-05	CcSEcCtD
Mirtazapine—Discomfort—Epirubicin—hematologic cancer	1.56e-05	4.67e-05	CcSEcCtD
Mirtazapine—Vomiting—Triamcinolone—hematologic cancer	1.56e-05	4.66e-05	CcSEcCtD
Mirtazapine—Malaise—Doxorubicin—hematologic cancer	1.55e-05	4.63e-05	CcSEcCtD
Mirtazapine—Rash—Triamcinolone—hematologic cancer	1.55e-05	4.62e-05	CcSEcCtD
Mirtazapine—Dry mouth—Epirubicin—hematologic cancer	1.55e-05	4.62e-05	CcSEcCtD
Mirtazapine—Dermatitis—Triamcinolone—hematologic cancer	1.54e-05	4.61e-05	CcSEcCtD
Mirtazapine—Vertigo—Doxorubicin—hematologic cancer	1.54e-05	4.61e-05	CcSEcCtD
Mirtazapine—Anorexia—Methotrexate—hematologic cancer	1.54e-05	4.61e-05	CcSEcCtD
Mirtazapine—Syncope—Doxorubicin—hematologic cancer	1.54e-05	4.6e-05	CcSEcCtD
Mirtazapine—Urticaria—Prednisone—hematologic cancer	1.54e-05	4.6e-05	CcSEcCtD
Mirtazapine—Leukopenia—Doxorubicin—hematologic cancer	1.54e-05	4.59e-05	CcSEcCtD
Mirtazapine—Headache—Triamcinolone—hematologic cancer	1.54e-05	4.59e-05	CcSEcCtD
Mirtazapine—Body temperature increased—Prednisone—hematologic cancer	1.53e-05	4.57e-05	CcSEcCtD
Mirtazapine—Abdominal pain—Prednisone—hematologic cancer	1.53e-05	4.57e-05	CcSEcCtD
Mirtazapine—Confusional state—Epirubicin—hematologic cancer	1.53e-05	4.56e-05	CcSEcCtD
Mirtazapine—Diarrhoea—Dexamethasone—hematologic cancer	1.52e-05	4.55e-05	CcSEcCtD
Mirtazapine—Diarrhoea—Betamethasone—hematologic cancer	1.52e-05	4.55e-05	CcSEcCtD
Mirtazapine—Palpitations—Doxorubicin—hematologic cancer	1.52e-05	4.53e-05	CcSEcCtD
Mirtazapine—Oedema—Epirubicin—hematologic cancer	1.51e-05	4.53e-05	CcSEcCtD
Mirtazapine—Hypotension—Methotrexate—hematologic cancer	1.51e-05	4.52e-05	CcSEcCtD
Mirtazapine—Loss of consciousness—Doxorubicin—hematologic cancer	1.51e-05	4.51e-05	CcSEcCtD
Mirtazapine—Infection—Epirubicin—hematologic cancer	1.5e-05	4.5e-05	CcSEcCtD
Mirtazapine—Cough—Doxorubicin—hematologic cancer	1.5e-05	4.48e-05	CcSEcCtD
Mirtazapine—Shock—Epirubicin—hematologic cancer	1.49e-05	4.45e-05	CcSEcCtD
Mirtazapine—Convulsion—Doxorubicin—hematologic cancer	1.49e-05	4.45e-05	CcSEcCtD
Mirtazapine—Nervous system disorder—Epirubicin—hematologic cancer	1.49e-05	4.44e-05	CcSEcCtD
Mirtazapine—Thrombocytopenia—Epirubicin—hematologic cancer	1.48e-05	4.43e-05	CcSEcCtD
Mirtazapine—Hypertension—Doxorubicin—hematologic cancer	1.48e-05	4.43e-05	CcSEcCtD
Mirtazapine—Tachycardia—Epirubicin—hematologic cancer	1.48e-05	4.42e-05	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.47e-05	4.41e-05	CcSEcCtD
Mirtazapine—Skin disorder—Epirubicin—hematologic cancer	1.47e-05	4.4e-05	CcSEcCtD
Mirtazapine—Dizziness—Dexamethasone—hematologic cancer	1.47e-05	4.39e-05	CcSEcCtD
Mirtazapine—Dizziness—Betamethasone—hematologic cancer	1.47e-05	4.39e-05	CcSEcCtD
Mirtazapine—Hyperhidrosis—Epirubicin—hematologic cancer	1.46e-05	4.38e-05	CcSEcCtD
Mirtazapine—Insomnia—Methotrexate—hematologic cancer	1.46e-05	4.37e-05	CcSEcCtD
Mirtazapine—Myalgia—Doxorubicin—hematologic cancer	1.46e-05	4.37e-05	CcSEcCtD
Mirtazapine—Arthralgia—Doxorubicin—hematologic cancer	1.46e-05	4.37e-05	CcSEcCtD
Mirtazapine—Chest pain—Doxorubicin—hematologic cancer	1.46e-05	4.37e-05	CcSEcCtD
Mirtazapine—Anxiety—Doxorubicin—hematologic cancer	1.46e-05	4.35e-05	CcSEcCtD
Mirtazapine—Nausea—Triamcinolone—hematologic cancer	1.46e-05	4.35e-05	CcSEcCtD
Mirtazapine—Paraesthesia—Methotrexate—hematologic cancer	1.45e-05	4.34e-05	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.45e-05	4.34e-05	CcSEcCtD
Mirtazapine—Discomfort—Doxorubicin—hematologic cancer	1.44e-05	4.32e-05	CcSEcCtD
Mirtazapine—Anorexia—Epirubicin—hematologic cancer	1.44e-05	4.31e-05	CcSEcCtD
Mirtazapine—Dyspnoea—Methotrexate—hematologic cancer	1.44e-05	4.31e-05	CcSEcCtD
Mirtazapine—Somnolence—Methotrexate—hematologic cancer	1.44e-05	4.3e-05	CcSEcCtD
Mirtazapine—Dry mouth—Doxorubicin—hematologic cancer	1.43e-05	4.27e-05	CcSEcCtD
Mirtazapine—Hypersensitivity—Prednisone—hematologic cancer	1.43e-05	4.26e-05	CcSEcCtD
Mirtazapine—Dyspepsia—Methotrexate—hematologic cancer	1.42e-05	4.26e-05	CcSEcCtD
Mirtazapine—Hypotension—Epirubicin—hematologic cancer	1.42e-05	4.23e-05	CcSEcCtD
Mirtazapine—Vomiting—Dexamethasone—hematologic cancer	1.41e-05	4.23e-05	CcSEcCtD
Mirtazapine—Vomiting—Betamethasone—hematologic cancer	1.41e-05	4.23e-05	CcSEcCtD
Mirtazapine—Confusional state—Doxorubicin—hematologic cancer	1.41e-05	4.22e-05	CcSEcCtD
Mirtazapine—Decreased appetite—Methotrexate—hematologic cancer	1.41e-05	4.2e-05	CcSEcCtD
Mirtazapine—Rash—Betamethasone—hematologic cancer	1.4e-05	4.19e-05	CcSEcCtD
Mirtazapine—Rash—Dexamethasone—hematologic cancer	1.4e-05	4.19e-05	CcSEcCtD
Mirtazapine—Oedema—Doxorubicin—hematologic cancer	1.4e-05	4.19e-05	CcSEcCtD
Mirtazapine—Dermatitis—Betamethasone—hematologic cancer	1.4e-05	4.19e-05	CcSEcCtD
Mirtazapine—Dermatitis—Dexamethasone—hematologic cancer	1.4e-05	4.19e-05	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.4e-05	4.18e-05	CcSEcCtD
Mirtazapine—Fatigue—Methotrexate—hematologic cancer	1.4e-05	4.17e-05	CcSEcCtD
Mirtazapine—Headache—Dexamethasone—hematologic cancer	1.39e-05	4.16e-05	CcSEcCtD
Mirtazapine—Headache—Betamethasone—hematologic cancer	1.39e-05	4.16e-05	CcSEcCtD
Mirtazapine—Infection—Doxorubicin—hematologic cancer	1.39e-05	4.16e-05	CcSEcCtD
Mirtazapine—Asthenia—Prednisone—hematologic cancer	1.39e-05	4.15e-05	CcSEcCtD
Mirtazapine—Pain—Methotrexate—hematologic cancer	1.38e-05	4.14e-05	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.38e-05	4.12e-05	CcSEcCtD
Mirtazapine—Shock—Doxorubicin—hematologic cancer	1.38e-05	4.12e-05	CcSEcCtD
Mirtazapine—Nervous system disorder—Doxorubicin—hematologic cancer	1.37e-05	4.11e-05	CcSEcCtD
Mirtazapine—Thrombocytopenia—Doxorubicin—hematologic cancer	1.37e-05	4.1e-05	CcSEcCtD
Mirtazapine—Pruritus—Prednisone—hematologic cancer	1.37e-05	4.09e-05	CcSEcCtD
Mirtazapine—Insomnia—Epirubicin—hematologic cancer	1.37e-05	4.09e-05	CcSEcCtD
Mirtazapine—Tachycardia—Doxorubicin—hematologic cancer	1.37e-05	4.09e-05	CcSEcCtD
Mirtazapine—Skin disorder—Doxorubicin—hematologic cancer	1.36e-05	4.07e-05	CcSEcCtD
Mirtazapine—Paraesthesia—Epirubicin—hematologic cancer	1.36e-05	4.06e-05	CcSEcCtD
Mirtazapine—Hyperhidrosis—Doxorubicin—hematologic cancer	1.35e-05	4.05e-05	CcSEcCtD
Mirtazapine—Dyspnoea—Epirubicin—hematologic cancer	1.35e-05	4.04e-05	CcSEcCtD
Mirtazapine—Somnolence—Epirubicin—hematologic cancer	1.35e-05	4.02e-05	CcSEcCtD
Mirtazapine—Anorexia—Doxorubicin—hematologic cancer	1.34e-05	3.99e-05	CcSEcCtD
Mirtazapine—Feeling abnormal—Methotrexate—hematologic cancer	1.33e-05	3.99e-05	CcSEcCtD
Mirtazapine—Dyspepsia—Epirubicin—hematologic cancer	1.33e-05	3.98e-05	CcSEcCtD
Mirtazapine—Diarrhoea—Prednisone—hematologic cancer	1.33e-05	3.96e-05	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Methotrexate—hematologic cancer	1.32e-05	3.96e-05	CcSEcCtD
Mirtazapine—Nausea—Dexamethasone—hematologic cancer	1.32e-05	3.95e-05	CcSEcCtD
Mirtazapine—Nausea—Betamethasone—hematologic cancer	1.32e-05	3.95e-05	CcSEcCtD
Mirtazapine—Decreased appetite—Epirubicin—hematologic cancer	1.32e-05	3.93e-05	CcSEcCtD
Mirtazapine—Hypotension—Doxorubicin—hematologic cancer	1.31e-05	3.91e-05	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.31e-05	3.91e-05	CcSEcCtD
Mirtazapine—Fatigue—Epirubicin—hematologic cancer	1.31e-05	3.9e-05	CcSEcCtD
Mirtazapine—Pain—Epirubicin—hematologic cancer	1.3e-05	3.87e-05	CcSEcCtD
Mirtazapine—Constipation—Epirubicin—hematologic cancer	1.3e-05	3.87e-05	CcSEcCtD
Mirtazapine—Urticaria—Methotrexate—hematologic cancer	1.29e-05	3.84e-05	CcSEcCtD
Mirtazapine—Dizziness—Prednisone—hematologic cancer	1.28e-05	3.83e-05	CcSEcCtD
Mirtazapine—Body temperature increased—Methotrexate—hematologic cancer	1.28e-05	3.82e-05	CcSEcCtD
Mirtazapine—Abdominal pain—Methotrexate—hematologic cancer	1.28e-05	3.82e-05	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.28e-05	3.82e-05	CcSEcCtD
Mirtazapine—Insomnia—Doxorubicin—hematologic cancer	1.27e-05	3.79e-05	CcSEcCtD
Mirtazapine—Paraesthesia—Doxorubicin—hematologic cancer	1.26e-05	3.76e-05	CcSEcCtD
Mirtazapine—Dyspnoea—Doxorubicin—hematologic cancer	1.25e-05	3.73e-05	CcSEcCtD
Mirtazapine—Feeling abnormal—Epirubicin—hematologic cancer	1.25e-05	3.73e-05	CcSEcCtD
Mirtazapine—Somnolence—Doxorubicin—hematologic cancer	1.25e-05	3.72e-05	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Epirubicin—hematologic cancer	1.24e-05	3.7e-05	CcSEcCtD
Mirtazapine—Dyspepsia—Doxorubicin—hematologic cancer	1.23e-05	3.69e-05	CcSEcCtD
Mirtazapine—Vomiting—Prednisone—hematologic cancer	1.23e-05	3.68e-05	CcSEcCtD
Mirtazapine—Rash—Prednisone—hematologic cancer	1.22e-05	3.65e-05	CcSEcCtD
Mirtazapine—Dermatitis—Prednisone—hematologic cancer	1.22e-05	3.65e-05	CcSEcCtD
Mirtazapine—Decreased appetite—Doxorubicin—hematologic cancer	1.22e-05	3.64e-05	CcSEcCtD
Mirtazapine—Headache—Prednisone—hematologic cancer	1.21e-05	3.63e-05	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.21e-05	3.62e-05	CcSEcCtD
Mirtazapine—Fatigue—Doxorubicin—hematologic cancer	1.21e-05	3.61e-05	CcSEcCtD
Mirtazapine—Urticaria—Epirubicin—hematologic cancer	1.2e-05	3.6e-05	CcSEcCtD
Mirtazapine—Pain—Doxorubicin—hematologic cancer	1.2e-05	3.58e-05	CcSEcCtD
Mirtazapine—Constipation—Doxorubicin—hematologic cancer	1.2e-05	3.58e-05	CcSEcCtD
Mirtazapine—Body temperature increased—Epirubicin—hematologic cancer	1.2e-05	3.58e-05	CcSEcCtD
Mirtazapine—Abdominal pain—Epirubicin—hematologic cancer	1.2e-05	3.58e-05	CcSEcCtD
Mirtazapine—Hypersensitivity—Methotrexate—hematologic cancer	1.19e-05	3.56e-05	CcSEcCtD
Mirtazapine—Asthenia—Methotrexate—hematologic cancer	1.16e-05	3.47e-05	CcSEcCtD
Mirtazapine—Feeling abnormal—Doxorubicin—hematologic cancer	1.15e-05	3.45e-05	CcSEcCtD
Mirtazapine—Nausea—Prednisone—hematologic cancer	1.15e-05	3.44e-05	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.15e-05	3.42e-05	CcSEcCtD
Mirtazapine—Pruritus—Methotrexate—hematologic cancer	1.15e-05	3.42e-05	CcSEcCtD
Mirtazapine—Hypersensitivity—Epirubicin—hematologic cancer	1.12e-05	3.33e-05	CcSEcCtD
Mirtazapine—Urticaria—Doxorubicin—hematologic cancer	1.11e-05	3.33e-05	CcSEcCtD
Mirtazapine—Abdominal pain—Doxorubicin—hematologic cancer	1.11e-05	3.31e-05	CcSEcCtD
Mirtazapine—Body temperature increased—Doxorubicin—hematologic cancer	1.11e-05	3.31e-05	CcSEcCtD
Mirtazapine—Diarrhoea—Methotrexate—hematologic cancer	1.11e-05	3.31e-05	CcSEcCtD
Mirtazapine—Asthenia—Epirubicin—hematologic cancer	1.09e-05	3.25e-05	CcSEcCtD
Mirtazapine—Pruritus—Epirubicin—hematologic cancer	1.07e-05	3.2e-05	CcSEcCtD
Mirtazapine—Dizziness—Methotrexate—hematologic cancer	1.07e-05	3.2e-05	CcSEcCtD
Mirtazapine—Diarrhoea—Epirubicin—hematologic cancer	1.04e-05	3.1e-05	CcSEcCtD
Mirtazapine—Hypersensitivity—Doxorubicin—hematologic cancer	1.03e-05	3.09e-05	CcSEcCtD
Mirtazapine—Vomiting—Methotrexate—hematologic cancer	1.03e-05	3.08e-05	CcSEcCtD
Mirtazapine—Rash—Methotrexate—hematologic cancer	1.02e-05	3.05e-05	CcSEcCtD
Mirtazapine—Dermatitis—Methotrexate—hematologic cancer	1.02e-05	3.05e-05	CcSEcCtD
Mirtazapine—Headache—Methotrexate—hematologic cancer	1.01e-05	3.03e-05	CcSEcCtD
Mirtazapine—Asthenia—Doxorubicin—hematologic cancer	1.01e-05	3e-05	CcSEcCtD
Mirtazapine—Dizziness—Epirubicin—hematologic cancer	1e-05	2.99e-05	CcSEcCtD
Mirtazapine—Pruritus—Doxorubicin—hematologic cancer	9.92e-06	2.96e-05	CcSEcCtD
Mirtazapine—Vomiting—Epirubicin—hematologic cancer	9.63e-06	2.88e-05	CcSEcCtD
Mirtazapine—Nausea—Methotrexate—hematologic cancer	9.61e-06	2.87e-05	CcSEcCtD
Mirtazapine—Diarrhoea—Doxorubicin—hematologic cancer	9.59e-06	2.87e-05	CcSEcCtD
Mirtazapine—Rash—Epirubicin—hematologic cancer	9.55e-06	2.85e-05	CcSEcCtD
Mirtazapine—Dermatitis—Epirubicin—hematologic cancer	9.54e-06	2.85e-05	CcSEcCtD
Mirtazapine—Headache—Epirubicin—hematologic cancer	9.49e-06	2.84e-05	CcSEcCtD
Mirtazapine—Dizziness—Doxorubicin—hematologic cancer	9.27e-06	2.77e-05	CcSEcCtD
Mirtazapine—Nausea—Epirubicin—hematologic cancer	9e-06	2.69e-05	CcSEcCtD
Mirtazapine—Vomiting—Doxorubicin—hematologic cancer	8.91e-06	2.66e-05	CcSEcCtD
Mirtazapine—Rash—Doxorubicin—hematologic cancer	8.84e-06	2.64e-05	CcSEcCtD
Mirtazapine—Dermatitis—Doxorubicin—hematologic cancer	8.83e-06	2.64e-05	CcSEcCtD
Mirtazapine—Headache—Doxorubicin—hematologic cancer	8.78e-06	2.62e-05	CcSEcCtD
Mirtazapine—Nausea—Doxorubicin—hematologic cancer	8.32e-06	2.49e-05	CcSEcCtD
Mirtazapine—HRH1—Signaling Pathways—CASP3—hematologic cancer	1.9e-06	1.52e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.9e-06	1.52e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL2—hematologic cancer	1.9e-06	1.52e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—STAT3—hematologic cancer	1.89e-06	1.52e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—IL6—hematologic cancer	1.89e-06	1.52e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—NRAS—hematologic cancer	1.89e-06	1.51e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—IL6—hematologic cancer	1.89e-06	1.51e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—PIK3CA—hematologic cancer	1.89e-06	1.51e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CCND1—hematologic cancer	1.88e-06	1.51e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PIK3CB—hematologic cancer	1.88e-06	1.51e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MTOR—hematologic cancer	1.88e-06	1.51e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—AKT1—hematologic cancer	1.88e-06	1.51e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—JUN—hematologic cancer	1.88e-06	1.51e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—VEGFA—hematologic cancer	1.87e-06	1.5e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CASP3—hematologic cancer	1.86e-06	1.49e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL2—hematologic cancer	1.86e-06	1.49e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—VEGFA—hematologic cancer	1.86e-06	1.49e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—SRC—hematologic cancer	1.86e-06	1.49e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—EP300—hematologic cancer	1.85e-06	1.49e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CCND1—hematologic cancer	1.85e-06	1.48e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—HRAS—hematologic cancer	1.85e-06	1.48e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—IL6—hematologic cancer	1.85e-06	1.48e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—STAT3—hematologic cancer	1.85e-06	1.48e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MAPK3—hematologic cancer	1.85e-06	1.48e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—JUN—hematologic cancer	1.85e-06	1.48e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CCND1—hematologic cancer	1.85e-06	1.48e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—NRAS—hematologic cancer	1.85e-06	1.48e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—JUN—hematologic cancer	1.84e-06	1.48e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—STAT3—hematologic cancer	1.84e-06	1.48e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—NRAS—hematologic cancer	1.84e-06	1.47e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.83e-06	1.47e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TP53—hematologic cancer	1.82e-06	1.46e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—KRAS—hematologic cancer	1.82e-06	1.46e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—HRAS—hematologic cancer	1.82e-06	1.46e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CDKN1A—hematologic cancer	1.82e-06	1.46e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PTEN—hematologic cancer	1.82e-06	1.46e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CCND1—hematologic cancer	1.81e-06	1.45e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—JUN—hematologic cancer	1.81e-06	1.45e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—VEGFA—hematologic cancer	1.81e-06	1.45e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MAPK3—hematologic cancer	1.81e-06	1.45e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—PIK3CA—hematologic cancer	1.8e-06	1.44e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MYC—hematologic cancer	1.8e-06	1.44e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—HRAS—hematologic cancer	1.8e-06	1.44e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TGFB1—hematologic cancer	1.79e-06	1.44e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CDKN1A—hematologic cancer	1.79e-06	1.44e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—STAT3—hematologic cancer	1.79e-06	1.44e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CDKN1A—hematologic cancer	1.79e-06	1.43e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PTEN—hematologic cancer	1.79e-06	1.43e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PIK3CB—hematologic cancer	1.79e-06	1.43e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—NRAS—hematologic cancer	1.79e-06	1.43e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PTEN—hematologic cancer	1.78e-06	1.43e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MAPK8—hematologic cancer	1.78e-06	1.42e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.77e-06	1.42e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—AKT1—hematologic cancer	1.77e-06	1.42e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—IL6—hematologic cancer	1.77e-06	1.42e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MAPK3—hematologic cancer	1.77e-06	1.42e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CDKN1B—hematologic cancer	1.77e-06	1.42e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.76e-06	1.41e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MAPK3—hematologic cancer	1.76e-06	1.41e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MYC—hematologic cancer	1.76e-06	1.41e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CDKN1A—hematologic cancer	1.75e-06	1.41e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TGFB1—hematologic cancer	1.75e-06	1.41e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PTEN—hematologic cancer	1.75e-06	1.4e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MAPK8—hematologic cancer	1.75e-06	1.4e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—AKT1—hematologic cancer	1.75e-06	1.4e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MAPK8—hematologic cancer	1.74e-06	1.4e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—HRAS—hematologic cancer	1.74e-06	1.4e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—IL6—hematologic cancer	1.74e-06	1.4e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—AKT1—hematologic cancer	1.74e-06	1.4e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TP53—hematologic cancer	1.74e-06	1.4e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—AKT1—hematologic cancer	1.74e-06	1.39e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.74e-06	1.39e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—EP300—hematologic cancer	1.73e-06	1.39e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CASP3—hematologic cancer	1.73e-06	1.39e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL2—hematologic cancer	1.73e-06	1.39e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—IL6—hematologic cancer	1.72e-06	1.38e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MYC—hematologic cancer	1.72e-06	1.38e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TGFB1—hematologic cancer	1.72e-06	1.37e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MAPK8—hematologic cancer	1.71e-06	1.37e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MAPK3—hematologic cancer	1.71e-06	1.37e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MYC—hematologic cancer	1.71e-06	1.37e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—AKT1—hematologic cancer	1.71e-06	1.37e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TGFB1—hematologic cancer	1.71e-06	1.37e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—EP300—hematologic cancer	1.7e-06	1.37e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—EP300—hematologic cancer	1.7e-06	1.36e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.7e-06	1.36e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—PIK3CA—hematologic cancer	1.69e-06	1.35e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.69e-06	1.35e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.69e-06	1.35e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCND1—hematologic cancer	1.68e-06	1.35e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—SRC—hematologic cancer	1.68e-06	1.35e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.68e-06	1.35e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—JUN—hematologic cancer	1.68e-06	1.35e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—PIK3CA—hematologic cancer	1.67e-06	1.34e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—IL6—hematologic cancer	1.67e-06	1.34e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—EP300—hematologic cancer	1.67e-06	1.34e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.67e-06	1.34e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—HRAS—hematologic cancer	1.67e-06	1.33e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MYC—hematologic cancer	1.66e-06	1.33e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—KRAS—hematologic cancer	1.66e-06	1.33e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—ALB—hematologic cancer	1.66e-06	1.33e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TGFB1—hematologic cancer	1.66e-06	1.33e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—SRC—hematologic cancer	1.66e-06	1.33e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—SRC—hematologic cancer	1.65e-06	1.33e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—ALB—hematologic cancer	1.65e-06	1.32e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—VEGFA—hematologic cancer	1.64e-06	1.32e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—AKT1—hematologic cancer	1.63e-06	1.31e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CDKN1A—hematologic cancer	1.63e-06	1.31e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PTEN—hematologic cancer	1.63e-06	1.3e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—KRAS—hematologic cancer	1.62e-06	1.3e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—STAT3—hematologic cancer	1.62e-06	1.3e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—SRC—hematologic cancer	1.62e-06	1.3e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.62e-06	1.3e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—NRAS—hematologic cancer	1.62e-06	1.3e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TP53—hematologic cancer	1.62e-06	1.3e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—VEGFA—hematologic cancer	1.61e-06	1.29e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—VEGFA—hematologic cancer	1.61e-06	1.29e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—AKT1—hematologic cancer	1.61e-06	1.29e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—STAT3—hematologic cancer	1.6e-06	1.28e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—STAT3—hematologic cancer	1.6e-06	1.28e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—NRAS—hematologic cancer	1.59e-06	1.28e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—IL6—hematologic cancer	1.59e-06	1.28e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—NRAS—hematologic cancer	1.59e-06	1.28e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MAPK8—hematologic cancer	1.59e-06	1.28e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.59e-06	1.27e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—KRAS—hematologic cancer	1.59e-06	1.27e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—AKT1—hematologic cancer	1.59e-06	1.27e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—VEGFA—hematologic cancer	1.58e-06	1.27e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—KRAS—hematologic cancer	1.58e-06	1.27e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.58e-06	1.26e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—STAT3—hematologic cancer	1.57e-06	1.25e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—NRAS—hematologic cancer	1.56e-06	1.25e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MAPK3—hematologic cancer	1.55e-06	1.24e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—EP300—hematologic cancer	1.55e-06	1.24e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—HRAS—hematologic cancer	1.55e-06	1.24e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTEN—hematologic cancer	1.54e-06	1.24e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—AKT1—hematologic cancer	1.54e-06	1.23e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—KRAS—hematologic cancer	1.54e-06	1.23e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MAPK3—hematologic cancer	1.53e-06	1.22e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—PIK3CA—hematologic cancer	1.53e-06	1.22e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MAPK3—hematologic cancer	1.52e-06	1.22e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MYC—hematologic cancer	1.51e-06	1.21e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—SRC—hematologic cancer	1.51e-06	1.21e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TGFB1—hematologic cancer	1.51e-06	1.21e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.5e-06	1.21e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MAPK3—hematologic cancer	1.5e-06	1.2e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—PIK3CA—hematologic cancer	1.49e-06	1.2e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.49e-06	1.19e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MYC—hematologic cancer	1.49e-06	1.19e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—IL6—hematologic cancer	1.48e-06	1.19e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MYC—hematologic cancer	1.48e-06	1.19e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TGFB1—hematologic cancer	1.48e-06	1.19e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TGFB1—hematologic cancer	1.48e-06	1.19e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TP53—hematologic cancer	1.48e-06	1.18e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—EP300—hematologic cancer	1.47e-06	1.18e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—AKT1—hematologic cancer	1.47e-06	1.18e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—VEGFA—hematologic cancer	1.47e-06	1.18e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.47e-06	1.18e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—PIK3CA—hematologic cancer	1.46e-06	1.17e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MYC—hematologic cancer	1.45e-06	1.17e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—STAT3—hematologic cancer	1.45e-06	1.17e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.45e-06	1.17e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—PIK3CA—hematologic cancer	1.45e-06	1.16e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TGFB1—hematologic cancer	1.45e-06	1.16e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—NRAS—hematologic cancer	1.45e-06	1.16e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TP53—hematologic cancer	1.44e-06	1.16e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.43e-06	1.14e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—PIK3CA—hematologic cancer	1.41e-06	1.13e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TP53—hematologic cancer	1.41e-06	1.13e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—HRAS—hematologic cancer	1.41e-06	1.13e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—ALB—hematologic cancer	1.41e-06	1.13e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TP53—hematologic cancer	1.4e-06	1.13e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—KRAS—hematologic cancer	1.4e-06	1.12e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MAPK3—hematologic cancer	1.39e-06	1.11e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—HRAS—hematologic cancer	1.38e-06	1.11e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—AKT1—hematologic cancer	1.38e-06	1.11e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—KRAS—hematologic cancer	1.37e-06	1.1e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PIK3CA—hematologic cancer	1.37e-06	1.1e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—KRAS—hematologic cancer	1.37e-06	1.1e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—AKT1—hematologic cancer	1.37e-06	1.1e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TP53—hematologic cancer	1.37e-06	1.1e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MYC—hematologic cancer	1.35e-06	1.08e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IL6—hematologic cancer	1.35e-06	1.08e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—HRAS—hematologic cancer	1.35e-06	1.08e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TGFB1—hematologic cancer	1.35e-06	1.08e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.35e-06	1.08e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—KRAS—hematologic cancer	1.34e-06	1.08e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—HRAS—hematologic cancer	1.34e-06	1.08e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IL6—hematologic cancer	1.32e-06	1.06e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—HRAS—hematologic cancer	1.31e-06	1.05e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IL6—hematologic cancer	1.29e-06	1.04e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL6—hematologic cancer	1.29e-06	1.03e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	1.28e-06	1.03e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTEN—hematologic cancer	1.27e-06	1.02e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PIK3CA—hematologic cancer	1.26e-06	1.01e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	1.26e-06	1.01e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTEN—hematologic cancer	1.26e-06	1.01e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.25e-06	1e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL6—hematologic cancer	1.25e-06	1e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—KRAS—hematologic cancer	1.25e-06	1e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—AKT1—hematologic cancer	1.25e-06	9.99e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.24e-06	9.96e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TP53—hematologic cancer	1.24e-06	9.94e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PIK3CA—hematologic cancer	1.23e-06	9.9e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TP53—hematologic cancer	1.22e-06	9.78e-06	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—AKT1—hematologic cancer	1.22e-06	9.78e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TP53—hematologic cancer	1.22e-06	9.76e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—EP300—hematologic cancer	1.21e-06	9.69e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—EP300—hematologic cancer	1.2e-06	9.6e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TP53—hematologic cancer	1.19e-06	9.58e-06	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—AKT1—hematologic cancer	1.19e-06	9.56e-06	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—AKT1—hematologic cancer	1.19e-06	9.51e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—HRAS—hematologic cancer	1.19e-06	9.5e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—HRAS—hematologic cancer	1.17e-06	9.35e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—HRAS—hematologic cancer	1.16e-06	9.33e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.16e-06	9.3e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—AKT1—hematologic cancer	1.15e-06	9.25e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PIK3CA—hematologic cancer	1.15e-06	9.2e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—HRAS—hematologic cancer	1.14e-06	9.16e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL6—hematologic cancer	1.13e-06	9.1e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—AKT1—hematologic cancer	1.12e-06	8.98e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL6—hematologic cancer	1.12e-06	8.95e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL6—hematologic cancer	1.11e-06	8.93e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TP53—hematologic cancer	1.11e-06	8.9e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.1e-06	8.82e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL6—hematologic cancer	1.09e-06	8.76e-06	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.09e-06	8.73e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ALB—hematologic cancer	1.09e-06	8.71e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTEN—hematologic cancer	1.07e-06	8.61e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—HRAS—hematologic cancer	1.06e-06	8.51e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—AKT1—hematologic cancer	1.05e-06	8.39e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.04e-06	8.33e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—AKT1—hematologic cancer	1.03e-06	8.26e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—AKT1—hematologic cancer	1.03e-06	8.24e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—EP300—hematologic cancer	1.02e-06	8.21e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL6—hematologic cancer	1.02e-06	8.14e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—AKT1—hematologic cancer	1.01e-06	8.09e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	9.59e-07	7.69e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—AKT1—hematologic cancer	9.37e-07	7.51e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	8.94e-07	7.17e-06	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—AKT1—hematologic cancer	8.9e-07	7.13e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	8.86e-07	7.1e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTEN—hematologic cancer	8.29e-07	6.64e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—EP300—hematologic cancer	7.9e-07	6.33e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	7.57e-07	6.07e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—AKT1—hematologic cancer	7.3e-07	5.85e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—AKT1—hematologic cancer	7.24e-07	5.8e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—AKT1—hematologic cancer	6.19e-07	4.96e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	5.85e-07	4.69e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—AKT1—hematologic cancer	4.78e-07	3.83e-06	CbGpPWpGaD
